tiprankstipranks
Advertisement
Advertisement

DE:67N0 Stock Latest News

Edding Genor Boosts Profit as Landmark Biotech Merger Drives New Growth
Company AnnouncementsEdding Genor Boosts Profit as Landmark Biotech Merger Drives New Growth
15d ago
Edding Genor Details Board and Committee Structure
PremiumCompany Announcements
Edding Genor Details Board and Committee Structure
15d ago
Edding Genor Sets March 2026 Board Meeting to Approve 2025 Results
PremiumCompany Announcements
Edding Genor Sets March 2026 Board Meeting to Approve 2025 Results
25d ago
Edding Genor Expands Global Rights to Key siRNA Drug as It Streamlines Nanopeptide Collaboration
PremiumCompany Announcements
Edding Genor Expands Global Rights to Key siRNA Drug as It Streamlines Nanopeptide Collaboration
1M ago
Edding Genor Advances siRNA Cholesterol Drug EDP167 Into Phase II Trial
PremiumCompany Announcements
Edding Genor Advances siRNA Cholesterol Drug EDP167 Into Phase II Trial
2M ago
Edding Genor Renames Group and Changes Hong Kong Stock Short Name
PremiumCompany AnnouncementsEdding Genor Renames Group and Changes Hong Kong Stock Short Name
2M ago
Edding Genor Launches Flexible On-Market Share Buyback Plan
Premium
Company Announcements
Edding Genor Launches Flexible On-Market Share Buyback Plan
3M ago
Edding Genor Outlines Board and Committee Structure to Bolster Governance
Premium
Company Announcements
Edding Genor Outlines Board and Committee Structure to Bolster Governance
3M ago
Edding Genor Completes Reverse Takeover Merger and Major Corporate Overhaul
PremiumCompany Announcements
Edding Genor Completes Reverse Takeover Merger and Major Corporate Overhaul
3M ago
Genor Biopharma Wins Approval to Drop Biotech “-B” Marker After Revenue-Boosting Merger
PremiumCompany Announcements
Genor Biopharma Wins Approval to Drop Biotech “-B” Marker After Revenue-Boosting Merger
4M ago
Genor Biopharma Shareholders Approve Merger, Whitewash Waiver and Capital Increase
PremiumCompany Announcements
Genor Biopharma Shareholders Approve Merger, Whitewash Waiver and Capital Increase
4M ago
Genor Biopharma’s Lerociclib Gains Inclusion in China’s National Reimbursement Drug List
PremiumCompany Announcements
Genor Biopharma’s Lerociclib Gains Inclusion in China’s National Reimbursement Drug List
4M ago
Genor Biopharma Announces EGM and Member Register Closure
PremiumCompany AnnouncementsGenor Biopharma Announces EGM and Member Register Closure
4M ago
Genor Biopharma Announces Strategic Merger and Corporate Restructuring
Premium
Company Announcements
Genor Biopharma Announces Strategic Merger and Corporate Restructuring
4M ago
Genor Biopharma Announces EGM for Merger and Retention Plan Approval
Premium
Company Announcements
Genor Biopharma Announces EGM for Merger and Retention Plan Approval
4M ago
Genor Biopharma Announces Major Corporate Actions and Proposed Merger
PremiumCompany Announcements
Genor Biopharma Announces Major Corporate Actions and Proposed Merger
5M ago
Genor Biopharma’s New Trispecific Antibody Study: A Potential Game-Changer in Cancer Treatment
PremiumCompany Announcements
Genor Biopharma’s New Trispecific Antibody Study: A Potential Game-Changer in Cancer Treatment
6M ago
67N0
Genor Biopharma Announces Major Acquisition and Strategic Changes
PremiumCompany Announcements
Genor Biopharma Announces Major Acquisition and Strategic Changes
6M ago
Genor Biopharma Announces Strategic Merger and Market Expansion Plans
PremiumCompany Announcements
Genor Biopharma Announces Strategic Merger and Market Expansion Plans
7M ago
Genor Biopharma Reports Revenue Growth and Strategic Advances in H1 2025
PremiumCompany AnnouncementsGenor Biopharma Reports Revenue Growth and Strategic Advances in H1 2025
8M ago
Genor Biopharma Reschedules Board Meeting for Interim Results
Premium
Company Announcements
Genor Biopharma Reschedules Board Meeting for Interim Results
8M ago
Genor Biopharma Announces Strategic Merger and Listing Plans
Premium
Company Announcements
Genor Biopharma Announces Strategic Merger and Listing Plans
8M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >